We found that in GBM and LGG, the high POLD4 group and low POLD4 group showed consistent differences in some signatures, such as CD8 T effector, immune checkpoint, antigen processing machinery, and EMT (Figure 5B,C). The gene discussed is POLD4; the disease is glioblastoma.